These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11126326)

  • 1. The population pharmacokinetics of digoxin in dogs with heart disease.
    Whittem T; Hogan D; Sisson D; Cooper T
    J Vet Pharmacol Ther; 2000 Aug; 23(4):261-3. PubMed ID: 11126326
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there still a role for digoxin in the treatment of cardiac disease?
    Gavaghan BJ
    Aust Vet J; 2000 Aug; 78(8):528-9. PubMed ID: 10979506
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal digoxin concentrations for patients with heart failure.
    de Denus S; Spinler SA
    JAMA; 2003 May; 289(20):2643; author reply 2643-4. PubMed ID: 12771103
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure.
    Souza FC; Baptista TM; Marques EB; Barros RB; Scaramello CB
    Int J Cardiol; 2015 Jan; 179():343-4. PubMed ID: 25464482
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of canine plasma kinetics of digoxin and digitoxin to therapeutic digitalization in the dog.
    Breznock EM
    Am J Vet Res; 1973 Aug; 34(8):993-9. PubMed ID: 4755779
    [No Abstract]   [Full Text] [Related]  

  • 6. Preferences of veterinarians for drugs to treat heart disease in dogs and cats.
    Watson AD; Church DB
    Aust Vet J; 1995 Nov; 72(11):401-3. PubMed ID: 8929183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of milrinone for treating heart failure in dogs.
    Kittleson MD
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):905-18. PubMed ID: 1949499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Digoxin].
    Yamamoto K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():403-5. PubMed ID: 15658349
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H
    Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine heart disease: progress and promise.
    Oyama MA
    J Small Anim Pract; 2008 Nov; 49(11):549-50. PubMed ID: 19006487
    [No Abstract]   [Full Text] [Related]  

  • 11. Digoxin for patients with heart failure in sinus rhythm.
    Saunders KB
    Lancet; 1997 Aug; 350(9076):519. PubMed ID: 9274603
    [No Abstract]   [Full Text] [Related]  

  • 12. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
    Nagai Y; Hayakawa T; Abe T; Nomura G
    Diabetes Care; 2000 Nov; 23(11):1703. PubMed ID: 11092296
    [No Abstract]   [Full Text] [Related]  

  • 13. Digoxin therapy.
    Merrett D
    Aust Vet J; 2000 Sep; 78(9):612-5. PubMed ID: 11022287
    [No Abstract]   [Full Text] [Related]  

  • 14. Current use of pimobendan in canine patients with heart disease.
    Boswood A
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):571-80. PubMed ID: 20610012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The practice of digoxin therapeutic drug monitoring.
    Barclay M; Begg E
    N Z Med J; 2003 Dec; 116(1187):U704. PubMed ID: 14752532
    [No Abstract]   [Full Text] [Related]  

  • 16. The effectiveness of taurine and levocarnitine in dogs with heart disease.
    Pion PD; Sanderson SL; Kittelson MD
    Vet Clin North Am Small Anim Pract; 1998 Nov; 28(6):1495-514, ix. PubMed ID: 10098250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking for consensus in treatment of cardiac disease.
    Smith CA
    J Am Vet Med Assoc; 1995 Feb; 206(3):307-12. PubMed ID: 7751234
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic accuracy of a hyperbolic model in predicting digoxin concentrations based on glomerular filtration rates.
    González-López J; Tutor JC
    Nefrologia; 2011; 31(5):573-8. PubMed ID: 21959724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic drug monitoring of digoxin in cardiac heart failure outpatients: comparisons of two analytical methods].
    Barros IC; Freitas EM; Rassi S; Carneiro WJ; Rodrigues CR; Honório TC; Teixeira Lde S; Rodríguez V; Cunha LC
    Farm Hosp; 2014 Jan; 38(1):38-43. PubMed ID: 24483858
    [No Abstract]   [Full Text] [Related]  

  • 20. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T
    Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.